Henoch–Schönlein purpura
- 1 September 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 22 (5) , 598-602
Abstract
To provide an update on recent advances in the genetic susceptibility, pathogenesis and treatment of Henoch-Schönlein purpura. Recent work has advanced our understanding of the genetic susceptibility and pathogenesis of Henoch-Schönlein purpura, but there are still significant gaps in our knowledge. Information concerning the most effective treatment of Henoch-Schönlein purpura has begun to emerge. Corticosteroid therapy reduces the duration and severity of abdominal and joint pain, but corticosteroids do not prevent the development of nephritis, or alter the natural history of Henoch-Schönlein purpura. The most effective treatment for severe nephritis remains unclear despite multiple, mostly retrospective reports investigating a variety of drugs. Despite recent progress, our understanding of the genetic susceptibility, pathogenesis and treatment of Henoch-Schönlein purpura remains incomplete. Further research is necessary in order to clearly define the genetic susceptibility and the pathogenesis of Henoch-Schönlein purpura. Multicenter clinical trials are needed to determine the most effective treatment of Henoch-Schönlein purpura, particularly for patients with severe nephritis.Keywords
This publication has 31 references indexed in Scilit:
- Successful Treatment of Prolonged Henoch-Schönlein Purpura With ColchicineClinical Pediatrics, 2009
- MEFV Mutations Modify the Clinical Presentation of Henoch-Schönlein PurpuraThe Journal of Rheumatology, 2008
- Henoch Schonlein purpura in childhood: clinical analysis of 254 cases over a 3-year periodClinical Rheumatology, 2008
- HLA class 1 associations in Henoch Schonlein purpura: increased and decreased frequenciesClinical Rheumatology, 2007
- Clinical update: Henoch-Schönlein purpuraThe Lancet, 2007
- Henoch Schonlein Purpura in Childhood: Epidemiological and Clinical Analysis of 150 Cases Over a 5-year Period and Review of LiteratureSeminars in Arthritis and Rheumatism, 2005
- Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpuraThe Journal of Pediatrics, 2003
- Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic originsThe Lancet, 2002
- Colchicine: 1998 updateSeminars in Arthritis and Rheumatism, 1998
- IMMUNOGENETICS OF HENOCH–SCHOENLEIN DISEASEEuropean Journal of Immunogenetics, 1997